Venture Capital

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

Federal integrator Tyto Athene hires a top AI expert from a rival to lead an aggressive 'AI-first' push for defense and intelligence contracts.

SoundThinking hires Mark43 veteran David Jochim to lead its TechnoLogic division, signaling a strategic push for operational excellence and delivery.

With a new CFO known for big-ticket financing and IPO readiness, clinical-stage OnCusp Therapeutics is gearing up for its next major growth spurt.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.

As CPG startups face a funding crunch and retail hurdles, one operator-led platform is expanding its 'access-first' model nationwide. Here's why it matters.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

Anduril's new partnership with BlueTIDE 2026 offers startups a direct path to integrate their tech into the Lattice AI platform, bypassing old hurdles.

Atamyo's new gene therapy shows remarkable early results, potentially halting a severe, progressive muscular dystrophy that affects children.

With a new VP and expanded partnerships, KIBO Commerce is capitalizing on the region's shift away from legacy tech to its flexible, composable solutions.

Japanese auto software firm Micware hits Nasdaq, raising $22.8M to power next-gen vehicle tech and challenge the industry's global giants.

Industrial AI leader showcases autonomous factory solutions in Kuala Lumpur, aligning with Malaysia's strategy to capture a larger slice of the global chip market.

With 799% revenue growth and major Fortune 10 deals, Energous proves wireless power is no longer a gadget gimmick but essential industrial tech.

As the space economy booms, a top TMT research firm launches dedicated coverage, signaling a new era of financial scrutiny for giants like SpaceX and Rocket Lab.

A new six-month semaglutide implant is entering clinical trials, aiming to solve the adherence crisis plaguing GLP-1 drugs like Ozempic and Wegovy.

COSIMO launches Geometric Video, a new AI-native format promising massive gains in accuracy and efficiency, potentially ending the era of brute-force scaling.

BUILD's 2026 BUILDFest launches a 'Shark Tank' for teens, showcasing how entrepreneurship education is shaping America's future workforce.

A new report reveals a record 4,434 satellites launched in 2025, as the industry's revenue soars and U.S. innovation solidifies its global dominance.

Cybersecurity firm iCOUNTER adds a CMO and CFO with track records of building market leaders and securing major exits, signaling aggressive expansion.

A new partnership aims to solve the massive underdiagnosis of a severe genetic disorder by offering free testing, a move with deep strategic implications.